ARWR News
Arrowhead Pharmaceuticals, Inc.
$58.02
-$0.34(-0.58%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
871.72K
52W Range
$36.73 - $95.49
Target Price
--
ARWR news: the latest Arrowhead Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest ARWR News
- Arrowhead Pharmaceuticals (ARWR) Receives a New Rating from UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Humana (HUM) and Arrowhead Pharmaceuticals (ARWR)TipRanks Newsroom · Oct 12, 2026
- Arrowhead’s Plozasiran Trial Completion Signals a Pivotal Moment for ARWR InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
- Arrowhead’s Plozasiran Hits Phase 3 Completion: What Investors Should Watch NextTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Arrowhead’s Plozasiran Trial Completion Marks a Key Catalyst in the Triglyceride MarketTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARWR | $58.02 | -0.6% | 871.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arrowhead Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW